EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CRB1 ‐Associated Inherited Retinal Dystrophies: Prospective Natural History Study With 4 Years of Follow‐Up

Jessica S Karuntu, Xuan-Thanh-An Nguyen, Mays Talib, Mary J van Schooneveld, Jan Wijnholds, Maria M van Genderen, Jos Twisk, Nicoline E Schalij-Delfos, Caroline C W Klaver, Ralph J Florijn, Jacoline B Ten Brink, Magda A Smoor und 4 weitere

Clinical & Experimental Ophthalmology · 2026

DOI: 10.1111/ceo.70142 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2026. Verfasst von Jessica S Karuntu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands. Hauptthemen laut MEDLINE: Membrane Proteins, Nerve Tissue Proteins, Mutation, Eye Proteins. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Algemene Nederlandse Vereniging ter voorkoming van Blindheid, Landelijke Stichting voor Blinden en Slechtzienden, Oogfonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The lack of validated and sensitive clinical endpoints remains a major challenge in the design of gene therapy trials for inherited retinal dystrophies (IRDs). This prospective longitudinal cohort study describes the natural disease progression of IRDs caused by pathogenic mutations in the Crumbs homologue 1 ( CRB1 ) gene, and identifies sensitive clinical endpoints.

Methods

In this single‐centre study, patients with genetically confirmed CRB1‐ associated IRD were assessed at baseline, 2‐year and 4‐year follow‐up. The phenotyping protocol included best‐corrected visual acuity (BCVA), Goldmann perimetry, mesopic microperimetry, full‐field stimulus testing (FST), ophthalmoscopy and assessment of retinal structural integrity on spectral‐domain optical coherence tomography and fundus autofluorescence.

Results

Twenty of the 22 enrolled patients completed the 4‐year follow‐up, including patients with retinitis pigmentosa ( n = 17), cone‐rod dystrophy ( n = 2) or macular dystrophy ( n = 1). Significant decreases were observed for BCVA (−6.2 ETDRS letters, 95% confidence interval [CI] −10.1 to −2.3; p = 0.003), V4e isopter seeing retinal area (−43.9 mm 2 , 95% CI, −72.3 to −15.5; p = 0.003) and mean sensitivity on microperimetry (−2.5 dB, 95% CI, −3.3 to −1.6; p < 0.001). FST thresholds for white, blue and red stimuli did not significantly change over 4 years ( p = 0.24; p = 0.78; p = 0.60, respectively). The continuity of the ellipsoid zone (EZ) and the external limiting membrane (ELM) on SD‐OCT were increasingly disrupted in six patients over the course of this study.

Conclusion

Except for FST responses, a significant decrease was observed over 4 years in the visual function parameters of BCVA, Goldmann perimetry and microperimetry and these may thus be used as sensitive clinical endpoints.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Membrane ProteinsNerve Tissue ProteinsMutationEye ProteinsRetinal DystrophiesHumansProspective StudiesVisual AcuityFemaleFollow-Up StudiesTomography, Optical CoherenceVisual Field TestsVisual FieldsMaleAdultMiddle AgedDisease ProgressionOphthalmoscopyYoung AdultAdolescentFluorescein AngiographyChild

Stichwörter der Autor:innen

CRB1 proteincone‐rod dystrophygenetic therapymacular degenerationnatural historyoutcome measureretinal dystrophiesretinitis pigmentosa

Substanzen

CRB1 protein, humanMembrane ProteinsNerve Tissue ProteinsEye Proteins

Autor:innen und Institutionen

  • Department of Ophthalmology, Leiden University Medical Center, Leiden, the Netherlands.
  • Department of Ophthalmology, Reinier de Graaf Hospital, Delft, the Netherlands.
  • Department of Ophthalmology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
  • Bartiméus, Diagnostic Center for Complex Visual Disorders, Zeist, the Netherlands.
  • Department of Ophthalmology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Epidemiology & Data Science, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Förderung

  • Algemene Nederlandse Vereniging ter voorkoming van Blindheid
  • Landelijke Stichting voor Blinden en Slechtzienden
  • Oogfonds
  • Curing Retinal Blindness Foundation
  • Stichting Retina Fonds
  • Bontius Stichting
  • Stichting Blindenhulp

Zitieren

APA

Karuntu, J. S., Nguyen, X. T., Talib, M., van Schooneveld, M. J., Wijnholds, J., van Genderen, M. M., Twisk, J., Schalij-Delfos, N. E., Klaver, C. C. W., Florijn, R. J., Ten Brink, J. B., Smoor, M. A., van den Born, L. I., Hoyng, C. B., Thiadens, A. A. H. J., & Boon, C. J. F. (2026). CRB1 ‐Associated Inherited Retinal Dystrophies: Prospective Natural History Study With 4 Years of Follow‐Up. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.70142

Vancouver

Karuntu JS, Nguyen XT, Talib M, van Schooneveld MJ, Wijnholds J, van Genderen MM, et al. CRB1 ‐Associated Inherited Retinal Dystrophies: Prospective Natural History Study With 4 Years of Follow‐Up. Clinical & Experimental Ophthalmology. 2026. doi:10.1111/ceo.70142

BibTeX
@article{Karuntu2026,
  author = {Karuntu, Jessica S and Nguyen, Xuan-Thanh-An and Talib, Mays and van Schooneveld, Mary J and Wijnholds, Jan and van Genderen, Maria M and Twisk, Jos and Schalij-Delfos, Nicoline E and Klaver, Caroline C W and Florijn, Ralph J and Ten Brink, Jacoline B and Smoor, Magda A and van den Born, L Ingeborgh and Hoyng, Carel B and Thiadens, Alberta A H J and Boon, Camiel J F},
  title = {CRB1 ‐Associated Inherited Retinal Dystrophies: Prospective Natural History Study With 4 Years of Follow‐Up},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2026},
  doi = {10.1111/ceo.70142}
}
Kostenlos starten →